---
$id: https://graph.org.ai/products/commodity/51111828
$type: Product
source: UNSPSC
code: "51111828"
title: "Cyproterone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyproterone

**UNSPSC Code**: 51111828
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-androgen with the molecular formula C22H27ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E61Q31EK2F, chemically known as 3h-cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1-beta,2-beta-dihydro-17-hydroxy- but generally known as cyproterone, which bears US NIH Compound Identifier 16417. European Medicines Agency schedules Cyproterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06877MIG. World Health Organization schedules cyproterone in its Anatomical Therapeutic Chemical (ATC) Classification. CYPROTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyproterone under HS 29372900 and SITC 54153. As of Q4 2014, CYPROTERONE remains the US FDA Preferred Term for this commodity. Cyproterone bears US NLM identifiers UMLS ID C0010621 and NCI Concept Code C407. SMILES: CLC1=CC2C(C3(C4C(C4)C(=O)C=C13)C)CCC1(C2CCC1(O)C(=O)C)C.

